131 related articles for article (PubMed ID: 24299784)
1. Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity.
Yao Z; Wu H; Zhang S; Du Y
Carbohydr Polym; 2014 Jan; 101():359-67. PubMed ID: 24299784
[TBL] [Abstract][Full Text] [Related]
2. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
Chen HM; Yan XJ; Wang F; Lin J; Xu WF
Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
[TBL] [Abstract][Full Text] [Related]
3. The immune regulation of κ-carrageenan oligosaccharide and its desulfated derivatives on LPS-activated microglial cells.
Xu L; Yao Z; Wu H; Wang F; Zhang S
Neurochem Int; 2012 Oct; 61(5):689-96. PubMed ID: 22766495
[TBL] [Abstract][Full Text] [Related]
4. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
5. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
[TBL] [Abstract][Full Text] [Related]
6. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
8. [Carrageenan oligosaccharides inhibit growth-factor binding and heparanase activity].
Chen HM; Gao Y; Yan XJ
Yao Xue Xue Bao; 2011 Mar; 46(3):280-4. PubMed ID: 21626781
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
10. Depolymerized products of lambda-carrageenan as a potent angiogenesis inhibitor.
Chen H; Yan X; Lin J; Wang F; Xu W
J Agric Food Chem; 2007 Aug; 55(17):6910-7. PubMed ID: 17661479
[TBL] [Abstract][Full Text] [Related]
11. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
[TBL] [Abstract][Full Text] [Related]
12. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
13. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides.
Yuan H; Song J; Li X; Li N; Dai J
Cancer Lett; 2006 Nov; 243(2):228-34. PubMed ID: 16410037
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis.
Wei A; Zhou D; Ruan J; Cai Y; Xiong C; Wu G
J Ethnopharmacol; 2012 Jan; 139(2):373-80. PubMed ID: 22123201
[TBL] [Abstract][Full Text] [Related]
17. Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma.
Zheng L; He X; Ma W; Dai B; Zhan Y; Zhang Y
Biomed Pharmacother; 2012 Oct; 66(7):499-505. PubMed ID: 22854322
[TBL] [Abstract][Full Text] [Related]
18. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
19. Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis.
Ilić M; Ilaš J; Dunkel P; Mátyus P; Boháč A; Liekens S; Kikelj D
Eur J Med Chem; 2012 Dec; 58():160-70. PubMed ID: 23124213
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]